Peptides

+MORE

Peptides

Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.

Peptides related products

Cat No.	Product Name	CAS No.	Product Description
V35400	H-Gly-Gly-His-Gly-OH	128114-56-7	H-Gly-Gly-His-Gly-OH is a peptide compound.
V35401	H-Gly-Gly-Leu-OH	14857-82-0	H-Gly-Gly-Leu-OH is a peptide compound.
V35402	H-Gly-Gly-Met-OH	17343-02-1	H-Gly-Gly-Met-OH is a bioactive peptide discovered by peptide screening.
V35403	H-Gly-Gly-NH2·HCl	16438-42-9	H-Gly-Gly-NH2·HCl is a peptide compound.
V35404	H-Gly-Gly-OBzl·p-tosylate	1738-82-5	H-Gly-Gly-OBzl·p-tosylate is a peptide compound.
V35283	H-Gly-Gly-OMe HCl	2776-60-5	H-Gly-Gly-OMe HCl is a peptide compound.
V35405	H-Gly-Gly-Sar-OH	38937-80-3	H-Gly-Gly-Sar-OH is a peptide compound.
V35406	H-Gly-Gly-Trp-OH	20762-32-7	H-Gly-Gly-Trp-OH is a peptide compound.
V35407	H-Gly-Gly-Tyr-OH	17343-07-6	H-Gly-Gly-Tyr-OH is a peptide compound.
V35408	H-Gly-Gly-Val-OH	20274-89-9	H-Gly-Gly-Val-OH is a peptide compound.
V35409	H-Gly-Gly-β-Ala-Gly-OH	23654-88-8	H-Gly-Gly-β-Ala-Gly-OH is a peptide compound.
V36452	H-Gly-His-Arg-Pro-OH		H-Gly-His-Arg-Pro-OH is a peptide compound.
V35410	H-Gly-His-OH	2489-13-6	(S)-2-(2-Aminoacetamido)-3-(1H-imidazol-4-yl)propanoic acid is a histidine analogue.
V35411	H-Gly-His-OH·HCl	3486-76-8	H-Gly-His-OH·HCl is a peptide compound.
V35281	H-Gly-Hyp-OH	24587-32-4	H-Gly-Hyp-OH is a peptide compound.
V36924	H-Gly-Ile-2-Nal-Trp-His-His-Tyr-OH		H-Gly-Ile-2-Nal-Trp-His-His-Tyr-OH is a peptide compound.
V35412	H-Gly-Ile-OH	19461-38-2	H-Gly-Ile-OH is a peptide compound.
V35413	H-Gly-Leu-Gly-OH	2576-67-2	H-Gly-Leu-Gly-OH is a peptide compound.
V35414	H-Gly-Leu-NH2·HCl	38173-66-9	H-Gly-Leu-NH2·HCl is a peptide compound.
V35415	H-Gly-Leu-Phe-OH	103213-38-3	H-Gly-Leu-Phe-OH (GLF), an immunostimulatory tripeptide developed from α-lactalbumin, inhibits alopecia, epidermal thickening, and adipocyte layer thinning induced by the anti-cancer compound etoposide.